Natural history and prognostic model of untreated breast cancer: a study based on the SEER database

Author:

Wang Dasong1,Yang Yan1,Yang Hongwei1,Yang Lei1,Chen Maoshan1,Fan Li1,He Yu1

Affiliation:

1. Suining Central Hospital

Abstract

Abstract Purpose: The primary aim of this study was to explore the natural history of breast cancer in the absence of treatment, aiming to identify the main factors affecting the prognosis of untreated breast cancer patients. Methods: Data for patients diagnosed with invasive breast cancer between 2010 and 2020 were obtained from the SEER database. The disease progression time was estimated by subtracting the median survival time of higher stages from that of lower stages. Untreated patients were divided into a training set and a validation set in a 7:3 ratio. In the training set, independent risk factors affecting prognosis were identified through univariate and multivariate cox proportional hazards regression analysis. A nomogram model was constructed using these risk factors to predict the prognosis of untreated patients, which was then validated in the validation set. Results: In untreated breast cancer patients, the progression time from stage I to stage II was 43 months, from stage II to stage III was 18 months, and from stage III to stage IV was 9 months. Age, tumor stage, ER status, PR status, histological grade, and marital status were identified as independent predictive factors for the overall survival of untreated breast cancer patients, and a nomogram model was constructed with these factors. Conclusion: The disease progression speed of breast cancer patients accelerates with the increase in tumor stage in the absence of treatment, and prognosis progressively worsens. Age, tumor stage, ER status, PR status, histological grade, and marital status are independent risk factors affecting the prognosis of untreated patients.

Publisher

Research Square Platform LLC

Reference40 articles.

1. Cancer statistics, 2023;Siegel RL;CA Cancer J Clin,2023

2. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;CA Cancer J Clin,2021

3. Cancer progress and priorities: breast cancer;Houghton SC;Cancer Epidemiol Biomarkers Prev,2021

4. Breast cancer statistics, 2022;Giaquinto AN;CA Cancer J Clin,2022

5. Global cancer in women: burden and trends;Torre LA;Cancer Epidemiol Biomarkers Prev,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3